Elevance Health, Inc. financial statements, FY2006–FY2025
Elevance Health, Inc. reported revenue of $199B and net income of $5.66B for the fiscal year ended 2025-12-31, as stated in its filing with US SEC EDGAR. Listed as ELV (NYSE). Fiscal year ends 31 December.
FactReportedAnnual figures as reported, in USD, 6 measures over 20 fiscal years. Each value links to the filing it came from. Nothing is restated, annualised, converted or estimated; a period a filing did not state is shown as a gap.
Annual results by fiscal year
| Fiscal year end | Revenue | Operating income | Net income | Total assets | Total liabilities | Stockholders' equity |
|---|---|---|---|---|---|---|
| 2025-12-31 | $199B | $7.2B | $5.66B | $121B | $77.5B | $43.9B |
| 2024-12-31 | $177B | $7.86B | $5.98B | $117B | $75.5B | $41.3B |
| 2023-12-31 | $171B | $8.5B | $5.99B | $109B | $69.5B | $39.3B |
| 2022-12-31 | $157B | $8.28B | $5.89B | $103B | $66.4B | $36.2B |
| 2021-12-31 | $139B | $7.56B | $6.16B | $97.5B | $61.3B | $36.1B |
| 2020-12-31 | $122B | $6.36B | $4.57B | $86.6B | $53.4B | $33.2B |
| 2019-12-31 | $104B | $6B | $4.81B | $77.5B | $45.7B | $31.7B |
| 2018-12-31 | $92.1B | $5.43B | $3.75B | $71.6B | $43B | $28.5B |
| 2017-12-31 | $90B | $4.17B | $3.84B | $70.5B | $44B | $26.5B |
| 2016-12-31 | $84.9B | $4.8B | $2.47B | $65.1B | $40B | $25.1B |
| 2015-12-31 | $79.2B | $4.75B | $2.56B | $61.7B | $38.7B | $23B |
| 2014-12-31 | $73.9B | $4.42B | $2.57B | $61.7B | $37.4B | $24.3B |
| 2013-12-31 | $71B | $4B | $2.49B | $59.6B | $34.8B | $24.8B |
| 2012-12-31 | $61.5B | $3.62B | $2.66B | $59B | $35.2B | $23.8B |
| 2011-12-31 | $60.7B | $3.78B | $2.65B | $52.2B | $28.9B | $23.3B |
| 2010-12-31 | $58.7B | $4.08B | $2.89B | $50.2B | $26.4B | $23.8B |
| 2009-12-31 | $64.9B | $4.18B | $4.75B | $52.1B | $27.3B | $24.9B |
| 2008-12-31 | $61.3B | $4.35B | $2.49B | $48.4B | $27B | $21.4B |
| 2007-12-31 | $61.2B | — | $3.35B | — | — | $23B |
| 2006-12-31 | — | — | — | — | — | $24.6B |
About these figures
Every number on this page is a fact with a filing behind it, retrieved from US SEC EDGAR and stored with the period it belongs to. Figures are shown as the company reported them for that period; a later restatement supersedes the earlier value rather than overwriting it. Market capitalisation is not shown anywhere on this site because no licensed price source is used; the profile shows reported public float where a filing states it.